MTPConnect – the Australian Government’s Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre – and BioPacific Partners – an organisation helping global companies
Read More
VIC manufacturer targeting Japanese cancer treatment
Melbourne medical manufacturer Telix Pharmaceuticals has partnered with a major Japanese engineering company to market its TLX-250 imaging program for cancer patients.
JFE Engineering is an expert of cyclotron
Read More
Read More
Australian biopharma manufacturer named global leader
Melbourne medical manufacturer Mesoblast has been named as the 2017 Global Technology Leader in the cell therapy industry.
A biopharma company specialising in cell therapies, its has used its proprietary
Read More
Read More
FDA considering ‘superbug’ drug manufactured in Sydney
The US Food and Drug Administration (FDA) will review an antibiotic made by a Sydney medical manufacturer that fights life-threatening blood diseases.
Recce is developing a new class of synthetic antibiotics
Read More
Read More
Australian drug manufacturer signs $2m government agreement
Drug manufacturer IDT Australia has signed an Active Pharmaceutical Ingredient (API) Development agreement with the Victorian state government.
The exact terms of the agreement have not been disclosure
Read More
Read More
CSL doubles manufacturing capacity
CSL Biotherapies, a subsidiary of CSL Limited Australia and one of the world’s leading manufacturers of influenza vaccine, has announced it has been awarded a contract by the United States Department of Health Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile.
Read More
Read More